145 related articles for article (PubMed ID: 12764738)
1. C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease.
Wieland A; Kerbl R; Berghold A; Schwinger W; Mann G; Urban C
Med Pediatr Oncol; 2003 Jul; 41(1):21-5. PubMed ID: 12764738
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).
Haase R; Vilser C; Mauz-Körholz C; Hasenclever D; Kluge R; Ruschke K; Borkhardt A; Seeger K; Lehrnbecher T; Kulozik A; Rößler J; Burdach S; Jürgens H; Körholz D
Klin Padiatr; 2012 Oct; 224(6):377-81. PubMed ID: 23047832
[TBL] [Abstract][Full Text] [Related]
3. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
4. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
8. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
[TBL] [Abstract][Full Text] [Related]
9. Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse.
Min CK; Kim SY; Eom KS; Kim YJ; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2006 Mar; 37(5):493-8. PubMed ID: 16435015
[TBL] [Abstract][Full Text] [Related]
10. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.
Avram MM; Fein PA; Paluch MM; Schloth T; Chattopadhyay J
Adv Perit Dial; 2005; 21():154-8. PubMed ID: 16686309
[TBL] [Abstract][Full Text] [Related]
11. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein serum levels are closely associated with lymph node status, but not with prognosis in patients with vulvar cancer.
Six L; Polterauer S; Grimm C; Seebacher V; Tempfer C; Heinze G; Joura E; Reinthaller A; Hefler LA
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):217-21. PubMed ID: 17459567
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.
Elstein D; Nir A; Klutstein M; Rudensky B; Zimran A
Blood Cells Mol Dis; 2005; 34(3):201-5. PubMed ID: 15885602
[TBL] [Abstract][Full Text] [Related]
18. [C-reactive protein as a useful prognostic marker in acute poisoning].
Sawiniec J; Gnyp L; Lewandowska-Stanek H
Przegl Lek; 2004; 61(4):356-8. PubMed ID: 15521602
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the model for end-stage liver disease and serum C-reactive protein as prognostic markers in intestinal failure patients on parenteral nutrition.
Putchakayala K; Polensky S; Fitzhugh J; Cohran V; Buchman A; Fryer J
JPEN J Parenter Enteral Nutr; 2009; 33(1):55-61. PubMed ID: 18941030
[TBL] [Abstract][Full Text] [Related]
20. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
